Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1441–1460 of 17,529 recalls

December 21, 2023· Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company

Recalled Item: Americaine

The Issue: Chemical Contamination: presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardCompleted
Refund
December 21, 2023· PFIZER

Recalled Item: Bleomycin for Injection

The Issue: Presence of particulate matter: glass

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 21, 2023· Pharma Nobis LLC

Recalled Item: Freskaro & revitalize Magnesium Citrate Saline Laxative Oral Solution

The Issue: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 21, 2023· Pharma Nobis LLC

Recalled Item: Good Neighbor Pharmacy

The Issue: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 21, 2023· Pfizer Inc.

Recalled Item: 4.2% Sodium Bicarbonate Injection

The Issue: Presence of Particulate Matter; identified as glass

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 21, 2023· Pharma Nobis LLC

Recalled Item: CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE

The Issue: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 21, 2023· Pharma Nobis LLC

Recalled Item: Freskaro & revitalize Magnesium Citrate Saline Laxative Oral Solution

The Issue: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 21, 2023· Pfizer Inc.

Recalled Item: 8.4 % Sodium Bicarbonate Injection

The Issue: Presence of Particulate Matter; identified as glass

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 21, 2023· Pfizer Inc.

Recalled Item: Atropine Sulfate Injection

The Issue: Presence of Particulate Matter; identified as glass

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
December 21, 2023· Pharma Nobis LLC

Recalled Item: Walgreens Dye-Free Magnesium Citrate Saline Laxative/Oral Solution

The Issue: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 20, 2023· Lupin Pharmaceuticals Inc.

Recalled Item: Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and

The Issue: CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 15, 2023· Dr. Reddy's Laboratories, Inc.

Recalled Item: Tacrolimus Capsules

The Issue: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
December 13, 2023· Private Label Partners, Inc.

Recalled Item: Selenium Sulfide 2.25% Shampoo

The Issue: CGMP Deviations: Stability data does not support expiry

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 12, 2023· GlaxoSmithKline LLC

Recalled Item: ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg. 1

The Issue: Failed Release Testing: Coarse Particle Mass for umeclidinium

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
December 11, 2023· Fagron, Inc

Recalled Item: NYSTATIN 2 BU

The Issue: Labeling: Label Error on Declared Strength: Assay value

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 11, 2023· Fagron, Inc

Recalled Item: NYSTATIN 150 MU

The Issue: Labeling: Label Error on Declared Strength: Assay value

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 11, 2023· Legacy Pharmaceutical Packaging LLC

Recalled Item: Sertraline Tablets

The Issue: CGMP Deviations: Inadequate line clearance which may result

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 11, 2023· Fagron, Inc

Recalled Item: NYSTATIN 5BU

The Issue: Labeling: Label Error on Declared Strength: Assay value

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 11, 2023· Fagron, Inc

Recalled Item: NYSTATIN 500 MU

The Issue: Labeling: Label Error on Declared Strength: Assay value

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
December 8, 2023· Azurity Pharmaceuticals, Inc.

Recalled Item: Eprontia (topiramate) oral solution

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund